EPO and anemia: This assumption is further supported by the fact that even in the subgroup of patients with eGFR values of < 60 mL/min/1.73 m2, where EPO production and circulating 1,25(OH)2D levels are reduced, vitamin D treatment had no effect on anemia prevalence and Hb levels.